[Localization diagnostics of malignant tumors using radioactive bleomycin (author's transl)].
Total-body scintigraphy with 111In-labeled bleomycin was performed in 66 patients with malignant solid tumors and systemic diseases of the lymphatic pathways (Hodgkin's lymphoma and non-Hodgkin's lymphoma). In 38 (58%) of 66 cases positive information was correct. In 12 (18%) of 66, scintigraphic information was correctly negative. With 16 out of 66 (24%), false positive or false negative informations were obtained.
D000230:Adenocarcinoma / Q000175:diagnosis; D001761:Bleomycin; D001943:Breast Neoplasms / Q000175:diagnosis; D002283:Carcinoma, Bronchogenic / Q000175:diagnosis; D002294:Carcinoma, Squamous Cell / Q000175:diagnosis; D004938:Esophageal Neoplasms / Q000175:diagnosis; D005188:False Negative Reactions; D005189:False Positive Reactions; D005260:Female; D006689:Hodgkin Disease / Q000175:diagnosis; D006801:Humans; D007204:Indium; D007890:Leiomyosarcoma / Q000175:diagnosis; D007945:Leukemia, Lymphoid / Q000175:diagnosis; D008175:Lung Neoplasms / Q000175:diagnosis; D008297:Male; D008545:Melanoma / Q000175:diagnosis; D009369:Neoplasms / Q000175:diagnosis*; D010051:Ovarian Neoplasms / Q000175:diagnosis; D010610:Pharyngeal Neoplasms / Q000175:diagnosis; D011877:Radionuclide Imaging; D013724:Teratoma / Q000175:diagnosis; D013736:Testicular Neoplasms / Q000175:diagnosis; D002583:Uterine Cervical Neoplasms / Q000175:diagnosis; D014846:Vulvar Neoplasms / Q000175:diagnosis
D007204:Indium; D001761:Bleomycin
Lokalisationsdiagnostik maligner Tumoren mit radioaktivem Bleomycin.